IceCure Medical to Report H1 2022 Results and Conduct Conference Call on August 15, 2022
- Tuesday, August 9, 2022, 7:14
- Business
- Add a comment
CAESAREA, Israel, Aug. 9, 2022 /PRNewswire/ — IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) (“IceCure” or the “Company”), developer of minimally-invasive cryoablation technology, the ProSense® System that destroys tumors by freezing as an alternative to surgical tumor removal, today…
About the Author
adminasapcorp has written 41562 stories on this site.